Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
September is Alopecia Awareness Month and, according to the NHS, 8 million women in the UK experience hair loss, which can lead to stress, poor self-esteem and even impact their relationships and ...